Preclinical Development Of A Therapeutic Anticancer Antibody To C-Met
Funder
National Health and Medical Research Council
Funding Amount
$435,530.00
Summary
Many common cancers cannot be effectively treated. A range of these cancers (e.g. gastric and lung cancer) display the molecule c-Met on their cell surface. c-Met promotes tumour growth; therefore, blocking c-Met is a promising strategy for treating these cancers. However, no antibodies or drugs that target c-Met have been licensed. The therapeutics that are being developed to target c-Met all have considerable limitations. Thus, there is an opportunity to develop a 'best-in-class' therapeutic.
Unravelling The Mechanism Of MHC Class-I Associated Drug Hypersensitivities
Funder
National Health and Medical Research Council
Funding Amount
$566,308.00
Summary
Some drugs cause adverse reactions that are life threatening. We think these reactions are mediated by killer T cells as they are genetically controlled by immune response genes that normally guide immunity to microbes. We will study immune reactions to the drug abacavir, used to treat HIV (AIDS); allopurinol used to prevent gout and carbamazepine, used to treat epilepsy. The study may also help devise better treatments for patients who experience severe forms of these reactions.
Optimisation Of Antimicrobial Therapy For Severe Bacterial Infections In Neonates And Young Children In Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$943,865.00
Summary
This study aims to provide important information on the way young Papua New Guinean children with serious bacterial infections handle antibiotics, including newer agents that may be required if bacterial resistance is confirmed or increases. The data will be used to optimise treatment, thus reducing mortality and potential adverse drug effects, in PNG nad other tropical countries, and may have implications for the developed world as well.
Molecular Pharmacology Of Chemokine Receptor Signalling In Cancer
Funder
National Health and Medical Research Council
Funding Amount
$371,770.00
Summary
Molecular pharmacology is the study of how hormones, neurotransmitters and pharmaceuticals interact with our cells through receptors, which transfer a signal across the cell membrane to change the function of that cell. Chemokine receptors are recognised to play a role in the development of many cancers. Understanding how these receptors work has enormous implications for improving our ability to develop better anti-cancer treatments with fewer side effects.
DYRK1A As A Novel Target For Glioblastoma Therapies
Funder
National Health and Medical Research Council
Funding Amount
$620,294.00
Summary
Glioblastoma is a form of brain cancer that is currently incurable. We have discovered that switching-off an enzyme called DYRK1A (using ‘DYRK1A inhibitors’) kills glioblastoma cells. This therapeutic advantage is even greater when combined with drugs approved for other cancers. This project will develop new DYRK1A inhibitors and examine a novel combination treatment for glioblastoma patients. This could initiate a novel therapy that could significantly extend patients’ lives.
Impact Of An Ivermectin Mass Drug Administration Program Against Endemic Scabies And Strongyloidiasis
Funder
National Health and Medical Research Council
Funding Amount
$1,289,786.00
Summary
Overseas studies suggest sustainable and long term benefits can be obtained through the use of ivermectin in mass drug administration programs to control parasitic infections. Our study will be a critical first step in establishing if such a program can be successful in a remote Indigenous community setting, where the disease burden from scabies and strongyloidiasis (threadworm infections) is very high.
Pharmacology Of Potential Anti-Tumour Agents: Iron Chelators Of The BpT Class
Funder
National Health and Medical Research Council
Funding Amount
$585,455.00
Summary
Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class Cancer cells have a high iron requirement for DNA synthesis and many clinical trials showed Fe chelators are effective anti-cancer drugs. Their potential to act as anti-tumour agents has been confirmed by the entrance of Triapine into widespread NCI clinical trials. In this NHMRC Renewal, we will perform pharmacological and preclinical studies to promote the development of BpT chelators as novel anti-tumour agents.
Stewarding thin markets: improving public sector market effectiveness. This project aims to develop methodologies to identify thin markets in the public service sector. Thin markets, where there are a low number of buyers or low number of sellers, are a major risk for governments utilising a personalised approach to service delivery. This project will develop new methodologies for identifying thin markets and determine ways emerging markets can be stewarded to better achieve their aims.
Facilitating Capacity Building in the Australian Not-For-Profit Sector through Improved Work Learning. This project aims to investigate how both formal and informal work learning can improve the governance, leadership, and management capacity of not-for-profit organisations (NFPs). The research aims to identify key competencies, and chart the needs, opportunities, preferences, and barriers to develop them on a national scale. Organisational mechanisms under managerial control are further examine ....Facilitating Capacity Building in the Australian Not-For-Profit Sector through Improved Work Learning. This project aims to investigate how both formal and informal work learning can improve the governance, leadership, and management capacity of not-for-profit organisations (NFPs). The research aims to identify key competencies, and chart the needs, opportunities, preferences, and barriers to develop them on a national scale. Organisational mechanisms under managerial control are further examined to understand what facilitates work learning within NFPs. Findings aims to inform theory, practice and policy about professional development and capacity building to enhance NFPs’ ability to make a strong social impact. Outcomes aim to significantly strengthen Australia’s social and economic fabric by building effectiveness within the critical NFP sector.Read moreRead less
The nature, extent and effect of infant removal by child protection. This project aims to provide new knowledge about the nature, extent and effect of removals of babies from their parents in Australia. Removal is the highest level of intervention by the child protection system, and one which some mothers experienced on multiple occasions. Little is known, however, about its incidence and effects, nor whether there are over-represented groups (e.g. Aboriginal mothers and babies) who would respon ....The nature, extent and effect of infant removal by child protection. This project aims to provide new knowledge about the nature, extent and effect of removals of babies from their parents in Australia. Removal is the highest level of intervention by the child protection system, and one which some mothers experienced on multiple occasions. Little is known, however, about its incidence and effects, nor whether there are over-represented groups (e.g. Aboriginal mothers and babies) who would respond to targeted interventions. This project aims to identify appropriate early intervention and prevention strategies, preventing the need for babies to spend their whole childhood in care at great financial and societal cost.Read moreRead less